JE CLEANTECH HOLDINGS LTD (JCSE)

KYG508752055 - Common Stock

1.22  +0.13 (+11.93%)

Fundamental Rating

2

JCSE gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 132 industry peers in the Machinery industry. JCSE has a bad profitability rating. Also its financial health evaluation is rather negative. JCSE does not seem to be growing, but still is valued expensively.



3

1. Profitability

1.1 Basic Checks

In the past year JCSE was profitable.
In the past year JCSE had a positive cash flow from operations.
Of the past 5 years JCSE 4 years were profitable.
JCSE had a positive operating cash flow in 4 of the past 5 years.

1.2 Ratios

JCSE's Return On Assets of 2.43% is in line compared to the rest of the industry. JCSE outperforms 44.62% of its industry peers.
JCSE's Return On Equity of 4.85% is in line compared to the rest of the industry. JCSE outperforms 44.62% of its industry peers.
JCSE has a Return On Invested Capital (5.20%) which is in line with its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for JCSE is significantly below the industry average of 11.15%.
The last Return On Invested Capital (5.20%) for JCSE is above the 3 year average (3.59%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 2.43%
ROE 4.85%
ROIC 5.2%
ROA(3y)1.61%
ROA(5y)2.91%
ROE(3y)3.47%
ROE(5y)9.53%
ROIC(3y)3.59%
ROIC(5y)10.51%

1.3 Margins

JCSE has a Profit Margin (4.20%) which is in line with its industry peers.
In the last couple of years the Profit Margin of JCSE has declined.
With a Operating Margin value of 6.94%, JCSE perfoms like the industry average, outperforming 46.15% of the companies in the same industry.
In the last couple of years the Operating Margin of JCSE has declined.
JCSE has a worse Gross Margin (25.56%) than 60.77% of its industry peers.
In the last couple of years the Gross Margin of JCSE has declined.
Industry RankSector Rank
OM 6.94%
PM (TTM) 4.2%
GM 25.56%
OM growth 3Y-30.23%
OM growth 5YN/A
PM growth 3Y-29.12%
PM growth 5YN/A
GM growth 3Y-4.24%
GM growth 5YN/A

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), JCSE is destroying value.
Compared to 1 year ago, JCSE has about the same amount of shares outstanding.
Compared to 1 year ago, JCSE has an improved debt to assets ratio.

2.2 Solvency

JCSE has an Altman-Z score of 1.49. This is a bad value and indicates that JCSE is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of JCSE (1.49) is worse than 76.92% of its industry peers.
JCSE has a debt to FCF ratio of 88.28. This is a negative value and a sign of low solvency as JCSE would need 88.28 years to pay back of all of its debts.
JCSE has a worse Debt to FCF ratio (88.28) than 66.15% of its industry peers.
JCSE has a Debt/Equity ratio of 0.21. This is a healthy value indicating a solid balance between debt and equity.
JCSE has a better Debt to Equity ratio (0.21) than 68.46% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 88.28
Altman-Z 1.49
ROIC/WACC0.62
WACC8.38%

2.3 Liquidity

JCSE has a Current Ratio of 2.06. This indicates that JCSE is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.06, JCSE is in line with its industry, outperforming 46.92% of the companies in the same industry.
JCSE has a Quick Ratio of 1.02. This is a normal value and indicates that JCSE is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.02, JCSE is not doing good in the industry: 65.38% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 2.06
Quick Ratio 1.02

0

3. Growth

3.1 Past

JCSE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -39.30%.
The earnings per share for JCSE have been decreasing by -33.34% on average. This is quite bad
Looking at the last year, JCSE shows a decrease in Revenue. The Revenue has decreased by -1.40% in the last year.
JCSE shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -5.55% yearly.
EPS 1Y (TTM)-39.3%
EPS 3Y-33.34%
EPS 5YN/A
EPS Q2Q%114.32%
Revenue 1Y (TTM)-1.4%
Revenue growth 3Y-5.55%
Revenue growth 5YN/A
Sales Q2Q%21.87%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

3

4. Valuation

4.1 Price/Earnings Ratio

JCSE is valuated reasonably with a Price/Earnings ratio of 10.17.
Compared to the rest of the industry, the Price/Earnings ratio of JCSE indicates a rather cheap valuation: JCSE is cheaper than 93.85% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 29.55. JCSE is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 10.17
Fwd PE N/A

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, JCSE is valued cheaply inside the industry as 97.69% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, JCSE is valued a bit more expensive than 60.77% of the companies in the same industry.
Industry RankSector Rank
P/FCF 82.13
EV/EBITDA 5.13

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for JCSE!.
Industry RankSector Rank
Dividend Yield N/A

JE CLEANTECH HOLDINGS LTD

NASDAQ:JCSE (11/29/2024, 11:55:20 AM)

1.22

+0.13 (+11.93%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap6.11M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 10.17
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.43%
ROE 4.85%
ROCE
ROIC
ROICexc
ROICexgc
OM 6.94%
PM (TTM) 4.2%
GM 25.56%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.58
Health
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 2.06
Quick Ratio 1.02
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-39.3%
EPS 3Y-33.34%
EPS 5Y
EPS Q2Q%
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-1.4%
Revenue growth 3Y-5.55%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y